{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:41:05Z","timestamp":1759588865487,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15591595"],"award-info":[{"award-number":["15591595"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.bone.2005.08.006","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T14:23:10Z","timestamp":1128435790000},"page":"206-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Bone morphogenetic protein activities are enhanced by 3\u2032,5\u2032-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells"],"prefix":"10.1016","volume":"38","author":[{"given":"Ryo","family":"Sugama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizumi","family":"Nomura-Furuwatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Takaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2005.08.006_bib1","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1097\/00007632-200212010-00005","article-title":"Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies","volume":"27","author":"Boden","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.bone.2005.08.006_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.gt.3301999","article-title":"Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors","volume":"10","author":"Chen","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.bone.2005.08.006_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00003086-200202000-00011","article-title":"Clinical evaluation of recombinant human bone morphogenetic protein-2","volume":"395","author":"Valentin-Opran","year":"2002","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2005.08.006_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S8756-3282(00)00450-6","article-title":"Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline","volume":"28","author":"Horiuchi","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.08.006_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S8756-3282(02)00681-6","article-title":"Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2","volume":"30","author":"Horiuchi","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.08.006_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00003086-199403000-00038","article-title":"Transfilter bone induction by Chinese hamster ovary (CHO) cells transfected by DNA encoding bone morphogenetic protein-4","volume":"300","author":"Takaoka","year":"1994","journal-title":"Clin. Orthop."},{"key":"10.1016\/j.bone.2005.08.006_bib7","first-page":"3231","article-title":"Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division","volume":"33","author":"Reznikoff","year":"1973","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2005.08.006_bib8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/j.1460-2075.1988.tb02949.x","article-title":"B cell ontogeny in murine embryo studied by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac","volume":"7","author":"Ogawa","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2005.08.006_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1083\/jcb.96.1.191","article-title":"In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria","volume":"96","author":"Sudo","year":"1983","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2005.08.006_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0006-291X(05)80208-6","article-title":"The non-osteogenic mouse pluripotent cell line, C3H10T1\/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2","volume":"172","author":"Katagiri","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2005.08.006_bib11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/bbrc.1996.0411","article-title":"Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2\/PA6","volume":"220","author":"Yamaguchi","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2005.08.006_bib12","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bone.2005.08.006_bib13","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1359\/jbmr.2003.18.10.1854","article-title":"Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation","volume":"18","author":"Nakamura","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.08.006_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0955-0674(99)00073-3","article-title":"Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions","volume":"12","author":"Soderling","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bone.2005.08.006_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0165-6147(90)90066-H","article-title":"Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors","volume":"11","author":"Beavo","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bone.2005.08.006_bib16","first-page":"319","article-title":"Study of antiosteoporotic agents in tissue culture","volume":"15","author":"Robin","year":"1984","journal-title":"J. Med."},{"key":"10.1016\/j.bone.2005.08.006_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1254\/jjp.79.477","article-title":"Effects of XT-44, a phosphodiesterase 4 inhibitor, in osteoblastgenesis and osteoclastgenesis in culture and its therapeutic effects in rat osteopenia models","volume":"79","author":"Waki","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bone.2005.08.006_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S8756-3282(00)00395-1","article-title":"Inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice","volume":"27","author":"Kinoshita","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.08.006_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0006-2952(97)00211-6","article-title":"Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4","volume":"54","author":"Miyamoto","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bone.2005.08.006_bib20","first-page":"137","article-title":"Studies on osteoporoses. XI. Effects of a methylxanthine derivative. A preliminary report","volume":"14","author":"Robin","year":"1983","journal-title":"J. Med."},{"key":"10.1016\/j.bone.2005.08.006_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S8756-3282(02)00839-6","article-title":"A phosphodiesterase inhibitor, pentoxifylline, enhances the bone morphogenetic protein-4 (BMP-4)-dependent differentiation of osteoprogenitor cells","volume":"31","author":"Tsutsumimoto","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.08.006_bib22","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1210\/endo.142.11.8499","article-title":"1-(5-oxohexyl)-3,7-Dimethylxanthine, a phosphodiesterase inhibitor, activates MAPK cascades and promotes osteoblast differentiation by a mechanism independent of PKA activation (pentoxifylline promotes osteoblast differentiation)","volume":"142","author":"Rawadi","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.08.006_bib23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1365-2443.2002.00599.x","article-title":"Two major Smad pathways in TGF-beta superfamily signalling","volume":"7","author":"Miyazawa","year":"2002","journal-title":"Genes Cells"},{"key":"10.1016\/j.bone.2005.08.006_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/bbrc.1998.8200","article-title":"Induction of Smad6 mRNA by bone morphogenetic proteins","volume":"244","author":"Takase","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2005.08.006_bib25","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1074\/jbc.275.9.6075","article-title":"Smad6 is a Smad1\/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter","volume":"275","author":"Ishida","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2005.08.006_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jcp.10421","article-title":"CREB cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter","volume":"198","author":"Ionescu","year":"2004","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.bone.2005.08.006_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.emboj.7600067","article-title":"Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells","volume":"23","author":"Maeda","year":"2004","journal-title":"EMBO J."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328205003339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328205003339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:31:44Z","timestamp":1757611904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328205003339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S8756328205003339"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2005.08.006","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone morphogenetic protein activities are enhanced by 3\u2032,5\u2032-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2005.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}